Multidisciplinary Clinical Approach to Cancer Patients with Immune-Related Adverse Events Induced by Checkpoint Inhibitors

by Londoño, Maria-Carlota, Reig, Maria
Published in Cancers (Basel) (2020)

The success of regorafenib in hepatocellular carcinoma in a world of failures. Learnings for future developments

by Reig, Maria, Díaz-González, Álvaro, Bruix, Jordi
Published in Oncotarget (2017)

Natural history and staging for hepatocellular carcinoma

by Forner, Alejandro, Rodríguez‐Lopez, Carlos, Reig, María
Published in Clin Liver Dis (Hoboken) (2013)

Evolución natural y estratificación del carcinoma hepatocelular

by Forner, Alejandro, Rodríguez‐López, Carlos, Reig, María
Published in Clin Liver Dis (Hoboken) (2013)

Systemic therapy for hepatocellular carcinoma: trial enrichment does not guarantee success

by Da Fonseca, Leonardo G., Reig, Maria, Bruix, Jordi
Published in Oncotarget (2018)

Hepatocellular Carcinoma Recurrence in HCV Patients Treated with Direct Antiviral Agents

by Sanduzzi-Zamparelli, Marco, Boix, Loreto, Leal, Cassia, Reig, María
Published in Viruses (2019)

HEPATOCELLULAR CARCINOMA: NOVEL MOLECULAR APPROACHES FOR DIAGNOSIS, PROGNOSIS AND THERAPY

by Villanueva, Augusto, Minguez, Beatriz, Forner, Alejandro, Reig, Maria, Llovet, Josep M.
Published 2010

Approach of the patient with a liver mass

by Rodríguez de Lope, Carlos, Reig, María E, Darnell, Anna, Forner, Alejandro
Published in Frontline Gastroenterol (2012)

Diagnosis and management of toxicities of immune checkpoint inhibitors in hepatocellular carcinoma

by Sangro, Bruno, Chan, Stephen L., Meyer, Tim, Reig, María, El-Khoueiry, Anthony, Galle, Peter R.
Published in J Hepatol (2020)

Controversies in the management of hepatocellular carcinoma

by Forner, Alejandro, Da Fonseca, Leonardo G, Díaz-González, Álvaro, Sanduzzi-Zamparelli, Marco, Reig, María, Bruix, Jordi
Published in JHEP Rep (2019)

The TGF-β Pathway: A Pharmacological Target in Hepatocellular Carcinoma?

by Gonzalez-Sanchez, Ester, Vaquero, Javier, Férnandez-Barrena, Maite G., Lasarte, Juan José, Avila, Matías A., Sarobe, Pablo, Reig, María, Calvo, Mariona, Fabregat, Isabel
Published in Cancers (Basel) (2021)

Progression-Free Survival Early Assessment Is a Robust Surrogate Endpoint of Overall Survival in Immunotherapy Trials of Hepatocellular Carcinoma

by Cabibbo, Giuseppe, Celsa, Ciro, Enea, Marco, Battaglia, Salvatore, Rizzo, Giacomo Emanuele Maria, Busacca, Anita, Matranga, Domenica, Attanasio, Massimo, Reig, Maria, Craxì, Antonio, Cammà, Calogero
Published in Cancers (Basel) (2020)

Regorafenib Alteration of the BCL-xL/MCL-1 Ratio Provides a Therapeutic Opportunity for BH3-Mimetics in Hepatocellular Carcinoma Models

by Cucarull, Blanca, Tutusaus, Anna, Subías, Miguel, Stefanovic, Milica, Hernáez-Alsina, Tania, Boix, Loreto, Reig, María, García de Frutos, Pablo, Marí, Montserrat, Colell, Anna, Bruix, Jordi, Morales, Albert
Published in Cancers (Basel) (2020)

Antiapoptotic BCL-2 proteins determine sorafenib/regorafenib resistance and BH3-mimetic efficacy in hepatocellular carcinoma

by Tutusaus, Anna, Stefanovic, Milica, Boix, Loreto, Cucarull, Blanca, Zamora, Aynara, Blasco, Laura, de Frutos, Pablo García, Reig, Maria, Fernandez-Checa, Jose C., Marí, Montserrat, Colell, Anna, Bruix, Jordi, Morales, Albert
Published in Oncotarget (2018)

Pattern of progression in advanced hepatocellular carcinoma treated with ramucirumab

by Reig, Maria, Galle, Peter R., Kudo, Masatoshi, Finn, Richard, Llovet, Josep M., Metti, Andrea L., Schelman, William R., Liang, Kun, Wang, Chunxiao, Widau, Ryan C., Abada, Paolo, Zhu, Andrew X.
Published in Liver Int (2020)

Activated Lymphocytes and Increased Risk of Dermatologic Adverse Events during Sorafenib Therapy for Hepatocellular Carcinoma

by Corominas, Josep, Sapena, Victor, Sanduzzi-Zamparelli, Marco, Millán, Cristina, Samper, Esther, Llarch, Neus, Iserte, Gemma, Torres, Ferràn, Da Fonseca, Leonardo G., Muñoz-Martínez, Sergio, Forner, Alejandro, Bruix, Jordi, Boix, Loreto, Reig, María
Published in Cancers (Basel) (2021)

Mutational profile of skin lesions in hepatocellular carcinoma patients under tyrosine kinase inhibition: a repercussion of a wide-spectrum activity

by da Fonseca, Leonardo G., Fuster-Anglada, Carla, Carrera, Cristina, Millán, Cristina, Samper, Esther, Sapena, Victor, Díaz-González, Álvaro, Sanduzzi-Zamparelli, Marco, Leal, Cassia, Forner, Alejandro, Bruix, Jordi, Reig, Maria, Boix, Loreto, Díaz, Alba
Published in Oncotarget (2021)

Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma

by Rimassa, Lorenza, Reig, Maria, Abbadessa, Giovanni, Peck-Radosavljevic, Markus, Harris, William, Zagonel, Vittorina, Pastorelli, Davide, Rota Caremoli, Elena, Porta, Camillo, Damjanov, Nevena, Patel, Hitendra, Daniele, Bruno, Lamar, Maria, Schwartz, Brian, Goldberg, Terri, Santoro, Armando, Bruix, Jordi
Published in World J Gastroenterol (2017)

Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs

by Díaz‐González, Álvaro, Sapena, Víctor, Boix, Loreto, Torres, Ferrán, Sanduzzi‐Zamparelli, Marco, Da Fonseca, Leonardo G., LLarch, Neus, Iserte, Gemma, Guedes, Cassia, Muñoz‐Martínez, Sergio, Darnell, Anna, Belmonte, Ernest, Rimola, Jordi, Forner, Alejandro, Ayuso, Carmen, Bruix, Jordi, Reig, María
Published in United European Gastroenterol J (2021)

Anti-miR-518d-5p overcomes liver tumor cell death resistance through mitochondrial activity

by Fernández-Tussy, Pablo, Rodríguez-Agudo, Rubén, Fernández-Ramos, David, Barbier-Torres, Lucía, Zubiete-Franco, Imanol, Davalillo, Sergio López de, Herraez, Elisa, Goikoetxea-Usandizaga, Naroa, Lachiondo-Ortega, Sofia, Simón, Jorge, Lopitz-Otsoa, Fernando, Juan, Virginia Gutiérrez-de, McCain, Misti V., Perugorria, Maria J., Mabe, Jon, Navasa, Nicolás, Rodrigues, Cecilia M. P., Fabregat, Isabel, Boix, Loreto, Sapena, Victor, Anguita, Juan, Lu, Shelly C., Mato, José M., Banales, Jesus M., Villa, Erica, Reeves, Helen L., Bruix, Jordi, Reig, Maria, Marin, Jose J. G., Delgado, Teresa C., Martínez-Chantar, María L.
Published in Cell Death Dis (2021)